TNF and disease arising from reactivation of latent virus: With the current development of new TNF inhibitor biologics which specifically inhibit solTNF and spare Tm-TNF in the treatment of chronic inflammatory disorders [22], [23], [24], [25], we investigated the role of Tm-TNF in controlling reactivation of therapeutically induced latent infection.